Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2010 1
2011 3
2012 2
2013 2
2014 3
2015 5
2016 4
2017 3
2018 11
2019 5
2020 4
2021 6
2022 10
2023 11
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Oncolytic viruses for cancer immunotherapy.
Hemminki O, Dos Santos JM, Hemminki A. Hemminki O, et al. J Hematol Oncol. 2020 Jun 29;13(1):84. doi: 10.1186/s13045-020-00922-1. J Hematol Oncol. 2020. PMID: 32600470 Free PMC article. Review.
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.
Kudling TV, Clubb JHA, Pakola S, Quixabeira DCA, Lähdeniemi IAK, Heiniö C, Arias V, Havunen R, Cervera-Carrascon V, Santos JM, Sutinen E, Räsänen J, Borenius K, Mäyränpää MI, Aaltonen E, Sorsa S, Hemminki O, Kanerva A, Verschuren EW, Ilonen I, Hemminki A. Kudling TV, et al. Among authors: hemminki o. Oncoimmunology. 2023 Aug 2;12(1):2241710. doi: 10.1080/2162402X.2023.2241710. eCollection 2023. Oncoimmunology. 2023. PMID: 37546696 Free PMC article.
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine.
Basnet S, Van der Heijden M, Quixabeira DCA, Jirovec E, Grönberg-Vähä-Koskela SAM, Clubb JHA, Kanerva A, Pakola S, Haybout L, Arias V, Hemminki O, Kudling T, Zafar S, Cervera-Carrascon V, Santos JM, Hemminki A. Basnet S, et al. Among authors: hemminki o. Mol Ther. 2024 Sep 4;32(9):3114-3127. doi: 10.1016/j.ymthe.2024.06.029. Epub 2024 Jun 22. Mol Ther. 2024. PMID: 38910324 Free PMC article.
Familial Risks Between Urolithiasis and Cancer.
Hemminki K, Hemminki O, Försti A, Sundquist J, Sundquist K, Li X. Hemminki K, et al. Among authors: hemminki o. Sci Rep. 2018 Feb 15;8(1):3083. doi: 10.1038/s41598-018-21410-0. Sci Rep. 2018. PMID: 29449591 Free PMC article.
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors.
Jirovec E, Quixabeira DCA, Clubb JHA, Pakola SA, Kudling T, Arias V, Haybout L, Jalkanen K, Alanko T, Monberg T, Khammari A, Dreno B, Svane IM, Block MS, Adamo DA, Mäenpää J, Kistler C, Sorsa S, Hemminki O, Kanerva A, Santos JM, Cervera-Carrascon V, Hemminki A. Jirovec E, et al. Among authors: hemminki o. J Exp Clin Cancer Res. 2024 Nov 6;43(1):297. doi: 10.1186/s13046-024-03219-0. J Exp Clin Cancer Res. 2024. PMID: 39506856 Free PMC article. Clinical Trial.
Family History of Head and Neck Cancers.
Li X, Koskinen AI, Hemminki O, Försti A, Sundquist J, Sundquist K, Hemminki K. Li X, et al. Among authors: hemminki o. Cancers (Basel). 2021 Aug 16;13(16):4115. doi: 10.3390/cancers13164115. Cancers (Basel). 2021. PMID: 34439270 Free PMC article.
Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes.
Hemminki K, Kiemeney LA, Morgans AK, Ranniko A, Pichler R, Hemminki O, Culig Z, Mulders P, Bangma CH. Hemminki K, et al. Among authors: hemminki o. Eur Urol Open Sci. 2024 Sep 13;69:13-20. doi: 10.1016/j.euros.2024.08.011. eCollection 2024 Nov. Eur Urol Open Sci. 2024. PMID: 39314911 Free PMC article.
Familial Urinary Bladder Cancer with Other Cancers.
Yu H, Hemminki O, Försti A, Sundquist K, Hemminki K. Yu H, et al. Among authors: hemminki o. Eur Urol Oncol. 2018 Dec;1(6):461-466. doi: 10.1016/j.euo.2018.06.002. Epub 2018 Jun 30. Eur Urol Oncol. 2018. PMID: 31158089
73 results